1. Home
  2. LUV vs MRNA Comparison

LUV vs MRNA Comparison

Compare LUV & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southwest Airlines Company

LUV

Southwest Airlines Company

HOLD

Current Price

$38.21

Market Cap

21.3B

ML Signal

HOLD

Logo Moderna Inc.

MRNA

Moderna Inc.

HOLD

Current Price

$46.85

Market Cap

21.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LUV
MRNA
Founded
1967
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.3B
21.5B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
LUV
MRNA
Price
$38.21
$46.85
Analyst Decision
Hold
Hold
Analyst Count
18
12
Target Price
$45.37
$34.27
AVG Volume (30 Days)
6.9M
5.0M
Earning Date
04-22-2026
05-01-2026
Dividend Yield
1.93%
N/A
EPS Growth
3.95
21.77
EPS
0.45
N/A
Revenue
N/A
$19,263,000,000.00
Revenue This Year
$16.57
$9.36
Revenue Next Year
$3.61
$15.43
P/E Ratio
$82.73
N/A
Revenue Growth
N/A
4.29
52 Week Low
$28.79
$22.28
52 Week High
$55.11
$59.55

Technical Indicators

Market Signals
Indicator
LUV
MRNA
Relative Strength Index (RSI) 44.63 39.91
Support Level $38.09 $23.52
Resistance Level $42.88 $55.36
Average True Range (ATR) 1.47 2.69
MACD -0.13 -0.90
Stochastic Oscillator 16.98 21.24

Price Performance

Historical Comparison
LUV
MRNA

About LUV Southwest Airlines Company

Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates nearly 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated in a single, open-seating cabin configuration in a point-to-point network. In early 2026, Southwest will modify its cabins to offer some rows with extra legroom and will update its ticketing process and merchandising to offer assigned seats and more fare categories, including a basic economy class that will more directly compete with other airlines' offerings and appear for the first time in travel aggregators' search results.

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Share on Social Networks: